直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

European IP Blog

No More Automatic COVID-19 Extensions at the EPO

June 1, 2020

Authored and Edited by K. Victoria Barker, Ph.D.; Nicholas Russell Philip Fox

In recent months, the EPO has announced various “COVID-19” extensions of time, allowing additional time for responding to certain time periods (see our blog post here). The final “COVID-19” extension period expires 2 June 2020, but most workplaces are still a long way from being back to “normal”. What does the absence of a formal COVID-19 extension mean for EPO users?

As noted in our previous blog post on this topic, many significant deadlines were excluded from this extension including the deadline for filing a divisional application, and the deadlines for filing written submissions.

Rather than providing a blanket extension of time for most (but not all) EPO time periods, the expiry of the “COVID-19” extensions of time means that if a time limit is now missed after 2 June 2020, the onus is on applicants to demonstrate that the time limit is missed due to a dislocation in the delivery or transmission of mail caused by an exceptional occurrence affecting the locality where an applicant, a party or their representative resides or has his place of business. If there is disruption due to the pandemic, and any document received late will be deemed to have been received in due time if the person concerned offers evidence that on any of the ten days preceding the day of expiry of a period, it was not possible to observe the time limit due to this exceptional occurrence and that the mailing or the transmission was effected at the latest on the fifth day after the end of the disruption.

Hence the main difference between the current situation and the situation prior to 2 June is that the EPO must now be presented with evidence that it was not possible to meet the time period. In accordance with J 13/05, the burden of proof to provide evidence of the dislocation of mail falls with the party requesting the remedy. While requests under Rule 134(5) EPC do not need to meet the “all due care” standard required for re-establishment of rights, there is no guarantee that a request will be granted.

It is not clear how many applicants were taking advantage of the previous extension regime. Given that it is possible to file documents with the EPO electronically, probably the new arrangements will limit extension to circumstance where due to the prevailing COVID-19 situation, an applicant is physically prevented from filing a response to the EPO for example due to a need and an inability to access an office in order to submit a response.

For further advice, please contact your European representative.

Tags

COVID-19, European Patent Office (EPO)

Contacts

K. Victoria Barker, Ph.D.
Associate
London
+44 (0)20 7864 2822
Email

Copyright © 2020 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information. 

Related Insights

Conference

2026 EDTX Bench Bar Conference

October 28-30, 2026

Fort Worth

Conference

Georgia Life Sciences Summit 2026

August 25-26, 2026

Sandy Springs

Lecture

IPIC/McGill Summer IP Course 2026: Understanding Trademarks

July 14, 2026

Montreal

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Charitable

Bridges From School to Work Gala 2026

June 22, 2026

Washington, DC

Charitable

Banding Together 2026

June 18, 2026

Washington, DC

Lecture

Munich Licensing Summer Course 2026

June 18-19, 2026

Munich

Conference

IPBC Global 2026

June 15-17, 2026

San Diego

Conference

2026 Copyright Society Annual Meeting

June 14-16, 2026

Louisville

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP